Drugs that contain Doxycycline
1. Oracea patents expiration
ORACEA Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5919775 | GALDERMA LABS LP | Method for inhibiting expression of inducible nitric oxide synthase with tetracycline |
Aug, 2016
(7 years ago) | |
| US5789395 | GALDERMA LABS LP | Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
Aug, 2016
(7 years ago) | |
| US10058564 | GALDERMA LABS LP | Methods of treating acne |
Apr, 2022
(2 years ago) | |
| US7232572 | GALDERMA LABS LP | Methods of treating rosacea |
Apr, 2022
(2 years ago) | |
| US9241946 | GALDERMA LABS LP | Methods of treating acne |
Apr, 2022
(2 years ago) | |
| US8603506 | GALDERMA LABS LP | Methods of treating acne |
Apr, 2022
(2 years ago) | |
| US7211267 | GALDERMA LABS LP | Methods of treating acne |
Apr, 2022
(2 years ago) | |
| US8394406 | GALDERMA LABS LP | Once daily formulations of tetracyclines |
Apr, 2024
(19 days ago) | |
| US8709478 | GALDERMA LABS LP | Once daily formulations of tetracyclines |
Apr, 2024
(19 days ago) | |
| US8394405 | GALDERMA LABS LP | Once daily formulations of tetracyclines |
Apr, 2024
(19 days ago) | |
| US8470364 | GALDERMA LABS LP | Once daily formulations of tetracyclines |
Apr, 2024
(19 days ago) | |
| US8206740 | GALDERMA LABS LP | Once daily formulations of tetracyclines |
Dec, 2025
(1 year, 7 months from now) | |
| US7749532 | GALDERMA LABS LP | Once daily formulations of tetracyclines |
Dec, 2027
(3 years from now) | |
Market Authorisation Date: 26 May, 2006
Treatment: Treatment of only inflammatory lesions (papules and pustules) of rosacea
Dosage: CAPSULE;ORAL
How can I launch a generic of ORACEA before it's drug patent expiration?
More Information on Dosage
ORACEA family patents
